NASDAQ:CSTL (Castle Biosciences, Inc.)

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes. We put people first-empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning.